Question 1

Does Squarepoint Ops own JANX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Squarepoint Ops holds 532,321 shares of JANX (Janux Therapeutics), worth $8.2M.

Question 2

How many shares of JANX does Squarepoint Ops own?

Accepted Answer

As of its Q2 2026 13F, Squarepoint Ops holds 532,321 shares of JANX (Janux Therapeutics).

Question 3

What is Squarepoint Ops' JANX position worth?

Accepted Answer

As of its Q2 2026 13F, Squarepoint Ops' JANX position is worth $8.2M.

Question 4

Is Squarepoint Ops buying or selling JANX?

Accepted Answer

In Q2 2026, Squarepoint Ops reduced its JANX position by 71,679 shares (-11.9%).

Question 5

When did Squarepoint Ops first buy JANX?

Accepted Answer

Squarepoint Ops first reported JANX in its Q1 2023 13F and has listed it in 14 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	532,321	-11.9%	$8.2M	0.0%	$15.36	0
2026-Q1	Increased	604,000	+54.5%	$8.4M	0.0%	$13.90	39
2025-Q4	Increased	390,952	+490.9%	$5.4M	0.0%	$13.80	44
2025-Q3	Decreased	66,161	-65.1%	$1.6M	0.0%	$24.44	0
2025-Q2	Increased	189,569	+230.0%	$4.4M	0.0%	$23.10	43
2025-Q1	Increased	57,448	+39.5%	$1.6M	0.0%	$27.00	34
2024-Q4	Increased	41,176	+155.1%	$2.2M	0.0%	$53.54	42
2024-Q3	Decreased	16,142	-50.9%	$733,331	0.0%	$46.25	0